ArticleFrontiers in pharmacology2022

Optimizing antidotal treatment with the oral HSP90 inhibitor TAS-116 against hydrochloric acid-induced pulmonary fibrosis in mice.

Pavel A Solopov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.